Generally, a rep will be detailing several products at once; Vascepa will be the primary detailed product
If Pfizer is willing to make Vascepa as their "primary detailed product" at least with those reps, it is a pretty safe assumption that Pfizer are very much interested in Vascepa and not just in Canada.